NZ506872A - Medium and method for viral propagation and growth - Google Patents
Medium and method for viral propagation and growthInfo
- Publication number
- NZ506872A NZ506872A NZ506872A NZ50687299A NZ506872A NZ 506872 A NZ506872 A NZ 506872A NZ 506872 A NZ506872 A NZ 506872A NZ 50687299 A NZ50687299 A NZ 50687299A NZ 506872 A NZ506872 A NZ 506872A
- Authority
- NZ
- New Zealand
- Prior art keywords
- medium
- cells
- viruses
- multiplication
- culture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9803333A FR2775983B1 (fr) | 1998-03-13 | 1998-03-13 | Milieu et procede de propagation et de multiplication virales |
PCT/FR1999/000578 WO1999047648A2 (fr) | 1998-03-13 | 1999-03-15 | Milieu et procede de propagation et de multiplication virales |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ506872A true NZ506872A (en) | 2002-03-01 |
Family
ID=9524203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ506872A NZ506872A (en) | 1998-03-13 | 1999-03-15 | Medium and method for viral propagation and growth |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1062324A2 (ko) |
JP (1) | JP2002506636A (ko) |
KR (1) | KR20010072556A (ko) |
CN (1) | CN1301297A (ko) |
AU (1) | AU752577B2 (ko) |
BR (1) | BR9908744A (ko) |
CA (1) | CA2322619A1 (ko) |
EA (1) | EA200000934A1 (ko) |
FR (1) | FR2775983B1 (ko) |
HU (1) | HUP0101081A3 (ko) |
IL (1) | IL138250A0 (ko) |
NZ (1) | NZ506872A (ko) |
PL (1) | PL343557A1 (ko) |
SK (1) | SK12882000A3 (ko) |
TR (1) | TR200002641T2 (ko) |
WO (1) | WO1999047648A2 (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
WO2002077206A1 (en) * | 2001-03-27 | 2002-10-03 | Vertex Pharmaceuticals Incorporated | Compositiona and methods useful for hcv infection |
CN101058800B (zh) | 2002-07-09 | 2013-03-13 | 巴克斯特国际有限公司 | 用于细胞培养的无动物蛋白质培养基 |
GB0304799D0 (en) | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
KR101423344B1 (ko) | 2006-01-04 | 2014-07-30 | 백스터 인터내셔널 인코포레이티드 | 올리고펩티드-무함유 세포 배양 배지를 이용하여 단백질을 발현시키는 방법 |
JP5458536B2 (ja) * | 2008-09-17 | 2014-04-02 | 不二製油株式会社 | 乳酸の製造方法及び乳酸発酵用添加剤 |
CN107129963A (zh) * | 2017-04-24 | 2017-09-05 | 浙江美保龙生物技术有限公司 | 一种df‑1细胞培养液添加剂及其制备方法、使用方法 |
CN107043739A (zh) * | 2017-04-24 | 2017-08-15 | 浙江美保龙生物技术有限公司 | 一种Vero细胞培养液添加剂及其制备方法、使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498537A (en) * | 1994-03-09 | 1996-03-12 | Cellco, Inc. | Serum-free production of packaged viral vector |
FR2732347A1 (fr) * | 1995-03-30 | 1996-10-04 | Bio Media | Extrait vegetal, son procede de preparation et ses applications en medecine humaine ou veterinaire |
ES2191296T3 (es) * | 1997-04-16 | 2003-09-01 | Feva N V | Extractos vegetales, metodo para su preparacion y sus aplicaciones en medicina humana y veterinaria. |
-
1998
- 1998-03-13 FR FR9803333A patent/FR2775983B1/fr not_active Expired - Fee Related
-
1999
- 1999-03-15 AU AU27352/99A patent/AU752577B2/en not_active Ceased
- 1999-03-15 EA EA200000934A patent/EA200000934A1/ru unknown
- 1999-03-15 NZ NZ506872A patent/NZ506872A/en unknown
- 1999-03-15 KR KR1020007010026A patent/KR20010072556A/ko not_active Application Discontinuation
- 1999-03-15 PL PL34355799A patent/PL343557A1/xx not_active Application Discontinuation
- 1999-03-15 CN CN99803965A patent/CN1301297A/zh active Pending
- 1999-03-15 SK SK1288-2000A patent/SK12882000A3/sk unknown
- 1999-03-15 WO PCT/FR1999/000578 patent/WO1999047648A2/fr not_active Application Discontinuation
- 1999-03-15 BR BR9908744A patent/BR9908744A/pt not_active IP Right Cessation
- 1999-03-15 IL IL13825099A patent/IL138250A0/xx unknown
- 1999-03-15 JP JP2000536831A patent/JP2002506636A/ja not_active Withdrawn
- 1999-03-15 TR TR200002641T patent/TR200002641T2/xx unknown
- 1999-03-15 EP EP99907713A patent/EP1062324A2/fr not_active Withdrawn
- 1999-03-15 CA CA 2322619 patent/CA2322619A1/en not_active Abandoned
- 1999-03-15 HU HU0101081A patent/HUP0101081A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0101081A2 (hu) | 2001-07-30 |
AU752577B2 (en) | 2002-09-26 |
IL138250A0 (en) | 2001-10-31 |
AU2735299A (en) | 1999-10-11 |
WO1999047648A3 (fr) | 1999-11-04 |
BR9908744A (pt) | 2000-12-26 |
FR2775983B1 (fr) | 2000-11-10 |
SK12882000A3 (sk) | 2001-05-10 |
EA200000934A1 (ru) | 2001-02-26 |
TR200002641T2 (tr) | 2000-11-21 |
CA2322619A1 (en) | 1999-09-23 |
HUP0101081A3 (en) | 2003-04-28 |
PL343557A1 (en) | 2001-08-27 |
WO1999047648A2 (fr) | 1999-09-23 |
KR20010072556A (ko) | 2001-07-31 |
JP2002506636A (ja) | 2002-03-05 |
EP1062324A2 (fr) | 2000-12-27 |
CN1301297A (zh) | 2001-06-27 |
FR2775983A1 (fr) | 1999-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0904351B1 (en) | Animal cells and processes for the replication of influenza viruses | |
CA2455189C (en) | Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture | |
FI121117B (fi) | Menetelmä biologisten tuotteiden tuottamiseksi proteiinittomassa viljelmässä | |
KR100797547B1 (ko) | 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법 | |
AU2002338666B2 (en) | Multiplication of viruses in a cell culture | |
ES2488818T3 (es) | Método para la producción a gran escala de virus | |
EP2614140B1 (en) | Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells | |
US6146873A (en) | Production of orthomyxoviruses in monkey kidney cells using protein-free media | |
KR20070060049A (ko) | 인플루엔자 백신의 제조방법 | |
AU752577B2 (en) | Medium and method for viral propagation and growth | |
CN113939311A (zh) | 灭活病毒组合物和寨卡疫苗制剂 | |
JP5762969B2 (ja) | pH安定性のエンベロープ付きウィルスの生産方法 | |
KR20210082119A (ko) | 베로 세포 배양용 저혈청 배지 조성물 및 이의 이용 | |
MXPA00008511A (es) | Medio y metodo para la propagacion y multiplicacion viral | |
CZ20003327A3 (cs) | Prostředí pro propagaci a multiplikaci virů a způsob propagace a multiplikace virů | |
KR20100017593A (ko) | 바이러스의 증식을 위한 2-단계 온도 프로파일 | |
CA2250714C (en) | Animal cells and processes for the replication of influenza viruses | |
WO2009132195A1 (en) | Immortal avian cell line and methods of use | |
WO2011134660A1 (en) | Production of viral components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |